TB Alliance moves two novel tuberculosis drugs into human trials
GUADALAJARA (10 October, 2017) -- TBA-7371 and sutezolid entered phase 1 clinical trials, TB Alliance announced today. Both compounds have proceeded through early preclinical development...




